Enteric Oxalate Secretion Mediated by Slc26a6 Defends against Hyperoxalemia in Murine Models of Chronic Kidney Disease.


Journal

Journal of the American Society of Nephrology : JASN
ISSN: 1533-3450
Titre abrégé: J Am Soc Nephrol
Pays: United States
ID NLM: 9013836

Informations de publication

Date de publication:
09 2020
Historique:
received: 28 01 2020
accepted: 01 05 2020
pubmed: 15 7 2020
medline: 4 3 2021
entrez: 15 7 2020
Statut: ppublish

Résumé

A state of oxalate homeostasis is maintained in patients with healthy kidney function. However, as GFR declines, plasma oxalate (P Feeding a diet high in soluble oxalate or weekly injections of aristolochic acid induced CKD in age- and sex-matched wild-type and Fecal oxalate excretion was enhanced in wild-type mice with CKD. This increase was abrogated in Slc26a6-mediated enteric oxalate secretion is critical in decreasing the body burden of oxalate in murine CKD models. Future studies are needed to address whether similar mechanisms contribute to intestinal oxalate elimination in humans to enhance extrarenal oxalate clearance.

Sections du résumé

BACKGROUND
A state of oxalate homeostasis is maintained in patients with healthy kidney function. However, as GFR declines, plasma oxalate (P
METHODS
Feeding a diet high in soluble oxalate or weekly injections of aristolochic acid induced CKD in age- and sex-matched wild-type and
RESULTS
Fecal oxalate excretion was enhanced in wild-type mice with CKD. This increase was abrogated in
CONCLUSIONS
Slc26a6-mediated enteric oxalate secretion is critical in decreasing the body burden of oxalate in murine CKD models. Future studies are needed to address whether similar mechanisms contribute to intestinal oxalate elimination in humans to enhance extrarenal oxalate clearance.

Identifiants

pubmed: 32660969
pii: ASN.2020010105
doi: 10.1681/ASN.2020010105
pmc: PMC7461683
doi:

Substances chimiques

Antiporters 0
Oxalates 0
Slc26a6 protein, mouse 0
Sulfate Transporters 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1987-1995

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK079310
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK033793
Pays : United States
Organisme : NIDDK NIH HHS
ID : R37 DK033793
Pays : United States

Informations de copyright

Copyright © 2020 by the American Society of Nephrology.

Références

Gut. 1997 Jul;41(1):56-9
pubmed: 9274472
Am J Kidney Dis. 2012 Oct;60(4):662-7
pubmed: 22739230
Kidney Int. 1973 Jul;4(1):61-6
pubmed: 4723994
J Am Soc Nephrol. 2017 Jan;28(1):242-249
pubmed: 27313231
Am J Physiol Gastrointest Liver Physiol. 2013 Oct 1;305(7):G520-7
pubmed: 23886857
Nephrol Dial Transplant. 1993;8(12):1333-7
pubmed: 8159301
Am J Physiol Gastrointest Liver Physiol. 2006 Apr;290(4):G719-28
pubmed: 16373425
Am J Physiol Cell Physiol. 2010 Jun;298(6):C1363-75
pubmed: 20219950
Nat Genet. 2006 Apr;38(4):474-8
pubmed: 16532010
J Physiol. 2008 Mar 1;586(5):1291-306
pubmed: 18174209
Nephron Extra. 2013 Jan 11;3(1):12-29
pubmed: 23610565
Surg Forum. 1973;24:540-2
pubmed: 4806090
Physiol Rev. 1997 Jan;77(1):257-302
pubmed: 9016304
Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9425-30
pubmed: 11459928
Am J Physiol Renal Physiol. 2016 Apr 15;310(8):F785-F795
pubmed: 26764204
Am J Physiol Cell Physiol. 2012 Jul 1;303(1):C52-7
pubmed: 22517357
Nephrol Dial Transplant. 1989;4(9):792-9
pubmed: 2516611
J Biol Chem. 2002 Sep 13;277(37):33963-7
pubmed: 12119287
Nephrol Dial Transplant. 2020 May 1;35(5):888-894
pubmed: 30165691
Am J Physiol Cell Physiol. 2011 Feb;300(2):C276-86
pubmed: 21068358
Kidney Int. 1998 Sep;54(3):921-5
pubmed: 9734617
J Am Soc Nephrol. 2002 Feb;13(2):431-6
pubmed: 11805172
Am J Physiol Gastrointest Liver Physiol. 2019 Jan 1;316(1):G82-G94
pubmed: 30383413
J Am Soc Nephrol. 1992 Nov;3(5):1098-104
pubmed: 1482750
Am J Transplant. 2005 Feb;5(2):323-9
pubmed: 15643992
J Physiol. 2003 May 15;549(Pt 1):3-19
pubmed: 12651923
J Am Soc Nephrol. 1994 Dec;5(6):1339-43
pubmed: 7893999
Am J Physiol Gastrointest Liver Physiol. 2002 Mar;282(3):G573-9
pubmed: 11842009
J Clin Invest. 2010 Mar;120(3):706-12
pubmed: 20160351
Kidney Int. 2013 Nov;84(5):895-901
pubmed: 23739234

Auteurs

Laura I Neumeier (LI)

Department of Nephrology and Hypertension, Friedrich Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.

Robert B Thomson (RB)

Department of Internal Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut.

Martin Reichel (M)

Department of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Berlin, Germany.

Kai-Uwe Eckardt (KU)

Department of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Berlin, Germany.

Peter S Aronson (PS)

Department of Internal Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut.
Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, Connecticut.

Felix Knauf (F)

Department of Internal Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut Felix.Knauf@charite.de.
Department of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Berlin, Germany.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH